Literature DB >> 28431605

Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study.

Monika Szots1, Morten Blaabjerg2, Gergely Orsi3, Pernille Iversen4, Daniel Kondziella5, Camilla G Madsen6, Ellen Garde7, Peter O Magnusson6, Peter Barsi8, Ferenc Nagy1, Hartwig R Siebner9, Zsolt Illes10.   

Abstract

BACKGROUND: Chronic cognitive deficits are frequent in leucin-rich glioma-inactivated 1 protein (LGI1) encephalitis. We examined structural and metabolic brain abnormalities following LGI1 encephalitis and correlated findings with acute and follow-up clinical outcomes.
METHODS: Nine patients underwent prospective multimodal 3 Tesla MRI 33.1±18months after disease onset, including automated volumetry, diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRS). Data were compared to 9 age- and sex-matched healthy controls.
RESULTS: Although extratemporal lesions were not present on MRI in the acute stage, tract-based spatial statistics analyses of DTI during follow-up showed widespread changes in the cerebral and cerebellar white matter (WM), most prominent in the anterior parts of the corona radiata, capsula interna and corpus callosum. MRS revealed lower glutamine/glutamate WM levels compared to controls. Higher cerebellar gray matter volume was associated with better function at disease onset (measured by the modified Rankin Scale), and higher putaminal volume was associated with better cognition by Addenbrooke's Cognitive Examination test at 23.4±7.6months.
CONCLUSIONS: Poor clinical outcome following LGI1 encephalitis is associated with global brain atrophy and disintegration of white matter tracts. The pathological changes affect not only temporomesial structures but also frontal lobes and the cerebellum.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-LGI1 antibody; Cognition; Diffusion tensor imaging; Limbic encephalitis; MR-spectroscopy; Volumetry

Mesh:

Substances:

Year:  2017        PMID: 28431605     DOI: 10.1016/j.jns.2017.03.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Rapidly progressive global cerebral atrophy in the setting of anti-LGI1 encephalitis.

Authors:  Anudeep Yelam; Elanagan Nagarajan; Pradeep C Bollu
Journal:  BMJ Case Rep       Date:  2019-05-24

2.  Selective Limbic Blood-Brain Barrier Breakdown in a Feline Model of Limbic Encephalitis with LGI1 Antibodies.

Authors:  Anna R Tröscher; Andrea Klang; Maria French; Lucía Quemada-Garrido; Sibylle Maria Kneissl; Christian G Bien; Ákos Pákozdy; Jan Bauer
Journal:  Front Immunol       Date:  2017-10-18       Impact factor: 7.561

Review 3.  Innate Immunity in the Central Nervous System: A Missing Piece of the Autoimmune Encephalitis Puzzle?

Authors:  Robb Wesselingh; Helmut Butzkueven; Katherine Buzzard; David Tarlinton; Terence J O'Brien; Mastura Monif
Journal:  Front Immunol       Date:  2019-09-10       Impact factor: 7.561

4.  Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies.

Authors:  Jianping Qiao; Xiuhe Zhao; Shengjun Wang; Anning Li; Zhishun Wang; Chongfeng Cao; Qing Wang
Journal:  Front Neurosci       Date:  2020-04-03       Impact factor: 4.677

5.  Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.

Authors:  Eero Rissanen; Kelsey Carter; Steven Cicero; John Ficke; Marie Kijewski; Mi-Ae Park; Joseph Kijewski; Emily Stern; Tanuja Chitnis; David Silbersweig; Howard L Weiner; Chun K Kim; Jennifer Lyons; Joshua P Klein; Shamik Bhattacharyya; Tarun Singhal
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-01-28

6.  LGI1 antibody encephalitis: acute treatment comparisons and outcome.

Authors:  Andrew Rodriguez; C J Klein; Elia Sechi; Eva Alden; Michael R Basso; Shehroo Pudumjee; Sean J Pittock; Andrew McKeon; Jeffrey W Britton; A Sebastian Lopez-Chiriboga; Anastasia Zekeridou; Nicholas L Zalewski; B F Boeve; Gregory S Day; Avi Gadoth; David Burkholder; Michel Toledano; Divyanshu Dubey; Eoin P Flanagan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-11-25       Impact factor: 10.154

7.  Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis.

Authors:  Isabelle Quadrio; Virginie Desestret; Pierre Lardeux; Anthony Fourier; Elise Peter; Aline Dorey; Sergio Muñiz-Castrillo; Alberto Vogrig; Géraldine Picard; Véronique Rogemond; Mathieu Verdurand; Maité Formaglio; Bastien Joubert; Caroline Froment Tilikete; Jérôme Honnorat
Journal:  J Neurol       Date:  2021-06-08       Impact factor: 4.849

8.  Single-center study of autoimmune encephalitis-related autoantibody testing in Hungary.

Authors:  Zsófia Hayden; Katalin Böröcz; Zsuzsanna Csizmadia; Péter Balogh; Zoltán Kellermayer; Kornélia Bodó; József Najbauer; Tímea Berki
Journal:  Brain Behav       Date:  2019-10-24       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.